Compare ICCC & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | ATLX |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.1M | 91.2M |
| IPO Year | 1995 | 2012 |
| Metric | ICCC | ATLX |
|---|---|---|
| Price | $9.88 | $2.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 12.4K | ★ 211.5K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.85 | 47.08 |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $26,493,169.00 | $92,491.00 |
| Revenue This Year | N/A | $64,564.67 |
| Revenue Next Year | N/A | $785.59 |
| P/E Ratio | $24.21 | ★ N/A |
| Revenue Growth | ★ 51.64 | N/A |
| 52 Week Low | $4.52 | $2.55 |
| 52 Week High | $12.10 | $8.25 |
| Indicator | ICCC | ATLX |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 31.50 |
| Support Level | $9.39 | N/A |
| Resistance Level | $10.16 | $3.45 |
| Average True Range (ATR) | 0.27 | 0.15 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 32.86 | 1.21 |
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project, located in Minas Gerais State in Brazil. The company is focused on producing and selling lithium concentrate, a key ingredient for the battery supply chain.